Iterum Therapeutics PLC (NAS:ITRM)
$ 1.43 -0.07 (-4.67%) Market Cap: 23.67 Mil Enterprise Value: 26.80 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q4 2023 Iterum Therapeutics PLC Earnings Call Transcript

Mar 28, 2024 / 12:30PM GMT
Release Date Price: $1.54 (-3.14%)
Operator

Hello, everyone, and welcome to the Iterum Therapeutics fourth quarter and full year 2023 financial results and business update. My name is Emily, and I'll be coordinating your call. (Operator Instructions)

I will now turn the call over to our host, Louise Barrett, Senior Vice President of Legal Affairs. Louise, please go ahead.

Louise Barrett
Iterum Therapeutics plc - SVP, Legal Affairs

Thank you, Emily. Good morning and welcome to Iterum Therapeutics' fourth quarter and full year 2023 financial results and business update conference call. Our press release for our fourth quarter and full results was issued earlier this morning and can be found on our website.

We are joined this morning by our Chief Executive Officer, Corey Fishman; and our Chief Financial Officer. Judy Matthews. Corey will provide some opening remarks. Judy will provide details on our financial results, and then we'll open the line to Q&A.

Before we begin, I'd like to remind you that some of the information presented on this conference call will contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot